Jasper Therapeutics launches cash tender offer to buy back outstanding warrants for $0.324 each

PUBT · 1d ago
Jasper Therapeutics launches cash tender offer to buy back outstanding warrants for $0.324 each
  • Jasper Therapeutics launched a cash tender offer to buy any and all outstanding common stock purchase warrants issued Sept. 18, 2025.
  • Offer price set at $0.324 per warrant in cash; tendered warrants will be retired and cancelled to reduce potential dilution.
  • Warrants allow purchase of one common share at a $2.92 exercise price; untendered warrants remain outstanding until March 18, 2030.
  • Offer scheduled to expire Nov. 6, 2026; about 12,345,707 warrants were outstanding as of Oct. 6, 2026.
  • If all warrants tender, expected cash outlay about $4 million, funded from cash on hand.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610070800PRIMZONEFULLFEED9841142) on October 07, 2026, and is solely responsible for the information contained therein.